LUXELE MED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LUXELE MED
Largest movements
- Cash +€86,909
up €86,909 (+883%), from €9,839 to €96,748
mainly Net result for the year (+€70,986) and Tax, wage and social debts (+€15,665)
- Tangible fixed assets -€5,167
down €5,167 (-35.2%), from €14,665 to €9,498
- Receivables within one year -€1,400
down €1,400 (-13.1%), from €10,650 to €9,250
- Reserves +€70,186
up €70,186 (+526%), from €13,335 to €83,521
- Tax, wage and social debts +€15,665
up €15,665 (+397%), from €3,947 to €19,612
- Other debts -€6,000
down €6,000 (-37.2%), from €16,110 to €10,110
- Gross operating margin +€76,254
up €76,254 (+395%), from €19,295 to €95,549
- Taxes +€15,427
up €15,427 (+416%), from €3,707 to €19,134
- Depreciation +€4,332
up €4,332 (+519%), from €835 to €5,167
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €36,441 | €116,739 | +€80,298 | +220% |
| Fixed assets | 21/28 | €14,665 | €9,498 | -€5,167 | -35.2% |
| Tangible fixed assets | 22/27 | €14,665 | €9,498 | -€5,167 | -35.2% |
| Furniture and vehicles | 24 | €14,665 | €9,498 | -€5,167 | -35.2% |
| Current assets | 29/58 | €21,776 | €107,241 | +€85,465 | +392% |
| Amounts receivable within one year | 40/41 | €10,650 | €9,250 | -€1,400 | -13.1% |
| Trade receivables | 40 | €10,650 | €9,250 | -€1,400 | -13.1% |
| Cash at bank and in hand | 54/58 | €9,839 | €96,748 | +€86,909 | +883% |
| Deferred charges and accrued income | 490/1 | €1,287 | €1,243 | -€44 | -3.4% |
| Total equity and liabilities | 10/49 | €36,441 | €116,739 | +€80,298 | +220% |
| Equity | 10/15 | €16,335 | €86,521 | +€70,186 | +430% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €13,335 | €83,521 | +€70,186 | +526% |
| Distributable reserves | 133 | €13,335 | €83,521 | +€70,186 | +526% |
| Amounts payable | 17/49 | €20,106 | €30,218 | +€10,112 | +50.3% |
| Amounts payable within one year | 42/48 | €20,070 | €30,218 | +€10,148 | +50.6% |
| Trade debts | 44 | €13 | €496 | +€483 | +3,715% |
| Suppliers | 440/4 | €13 | €496 | +€483 | +3,715% |
| Taxes, remuneration and social security | 45 | €3,947 | €19,612 | +€15,665 | +397% |
| Taxes | 450/3 | €3,947 | €19,612 | +€15,665 | +397% |
| Other amounts payable | 47/48 | €16,110 | €10,110 | -€6,000 | -37.2% |
| Accrued charges and deferred income | 492/3 | €36 | - | -€36 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €835 | €5,167 | +€4,332 | +519% |
| Other operating charges | 640/8 | €589 | €356 | -€233 | -39.6% |
| Gross operating margin | 9900 | €19,295 | €95,549 | +€76,254 | +395% |
| Operating profit (loss) | 9901 | €17,871 | €90,026 | +€72,155 | +404% |
| Financial income | 75/76B | - | €245 | +€245 | |
| Recurring financial income | 75 | - | €245 | +€245 | |
| Financial charges | 65/66B | €29 | €151 | +€122 | +421% |
| Recurring financial charges | 65 | €29 | €151 | +€122 | +421% |
| Profit (loss) for the period before taxes | 9903 | €17,842 | €90,120 | +€72,278 | +405% |
| Income taxes | 67/77 | €3,707 | €19,134 | +€15,427 | +416% |
| Profit (loss) for the period | 9904 | €14,135 | €70,986 | +€56,851 | +402% |
| Profit (loss) for the period to be appropriated | 9905 | €14,135 | €70,986 | +€56,851 | +402% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.